Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae

Pediatric Infectious Disease Journal

Volumn 15, Issue 10, 1996, Pages 932-939

  Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

amoxicillin clavulanate; drug resistant; Streptococcus pneumoniae

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; MACROLIDE; PENEM DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CONFERENCE PAPER; HUMAN; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PARENTERAL DRUG ADMINISTRATION; PENICILLIN RESISTANCE; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TECHNIQUE; UNITED STATES;

DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PREVALENCE; STREPTOCOCCUS PNEUMONIAE; WORLD HEALTH;

EID: 0029839988     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199610000-00030     Document Type: Conference Paper

References (65)

1. Kaplan SL. The emergence of resistant pneumococcus as a pathogen in childhood upper respiratory tract infections. Semin Respir Infect 1995;10:31-6.
2. Mufson MA. Streptococcus pneumoniae. In: Mandell GL, Douglass GR, Bennett JE, eds. Principles and practices of infectious diseases. 3rd ed. New York: Churchill Livingstone, 1990:1539-50.
3. Musher DM. Pneumococcal pneumonia including diagnosis and therapy of infections caused by penicillin-resistant strains. Infect Dis Clin North Am 1991;5:509-21.
4. Friedland IR, McCracken GH. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994;331:377-82.
5. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990;3:171-96.
6. Eriksen KR. Studies of induced resistance to penicillin in a pneumococcus type I. Acta Pathol Microbiol Scand 1945;22: 398-405.
7. Hansman D, Bullen MM. A resistant pneumococcus. Lancet 1967;2:264-5.
8. Hansman D, Glasgow H, Sturt J, Devitt L, Douglas R. Increased resistance to penicillin of pneumococci isolated from man. N Engl J Med 1971;284:175-7.
9. Jacobs MR, Koornhof HJ, Robins-Browne HJ, et al. Emergence of multiply resistant pneumococci. N Engl J Med 1978;299:735-40.
10. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992;15:77-83.
11. Munoz R, Coffey TJ, Daniels M, et al. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis 1991;164:302-6.
12. Klugman KP, Koornhof HJ, Kuhnle V. Clinical and nasopharyngeal isolates of unusual multiply resistant pneumococci. Am J Dis Child 1986;140:1186-90.
13. Shibl AM, Hussein SS. Surveillance of Streptococcus pneumoniae serotypes in Ridayh and their susceptibility to penicillin and other commonly prescribed antibiotics. J Antimicrob Agents Chemother 1992;29:149-57.
14. Yigla M, Finkelstein R, Hashman N, Green P, Cohn L, Merzbach D, Epidemiology and clinical spectrum of pneumococcal infections: an Israeli viewpoint. J Hosp Infect 1995;29: 57-64.
15. Lee HJ, Park JY, Jang SH, Kim JH, Kim EC, Choi KW. High incidence of resistance to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a university hospital in Korea. Clin Infect Dis 1995;20:826-35.
16. Kam KM, Luey KY, Fung SM, Yiu PP, Harden TJ, Cheung MM. Emergence of multiple-antibiotic-resistant Streptococcus pneumoniae in Hong Kong. Antimicrob Agents Chemother 1995;39:2667-70.
17. Appelbaum PC. New prospects for antibacterial agents against multi-drug resistant pneumococci. Microb Drug Resist 1995;1:43-8.
18. Baquero F, Martinez-Beltran J, Loza E. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 1991;28(Suppl C):31-8.
19. Marton A. Pneumococcal antimicrobial resistance: the problem in Hungary. Clin Infect Dis 1992;15:106-11.
20. del Castillo F, Garcia-Perea A, Baquero-Artigao F. Bacteriology of acute otitis media in Spain: a prospective study based on tympanocentesis. Pediatr Infect Dis J 1996;15:541-3.
21. Fenoll A, Martin Bourgon C, Munoz R, Viciosos D, Casal J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev Infect Dis 1991;13:56-60.
22. Latorre C, Juncosa T, Sanfeliu I. Antibiotic resistance and serotypes of 100 Streptococcus pneumoniae strains isolated in a children's hospital in Barcelona, Spain. Antimicrob Agents Chemother 1985;28:357-9.
23. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333: 474-80.
24. Soares S, Kristinsson KG, Musser JM, Tomasz A. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis 1993;168:158-63.
25. MacGowen AP, Brown NM, Holt HA, Lovering AM, McCulloch SY, Reeves DS. An eight-year survey of the antimicrobial susceptibility patterns of 85 971 bacteria isolated from patients in a district general hospital and the local community. J Antimicrob Chemother 1993;31:543-57.
26. Marchese A, Debbia EA, Arvigo A, Pesce A, Schito GA. Susceptibility of Streptococcus pneumoniae strains in Italy to penicillin and ten other antibiotics. J Antimicrob Chemother 1995;36:833-7.
27. Reinert RR, Queck A, Kaufhold A, Kresken M, Lutticken R. Antimicrobial resistance and type distribution of Streptococcus pneumoniae isolates causing systemic infections in Germany, 1992-1994. Clin Infect Dis 1995;21:1398-401.
28. Gregson D, Bialkowska-Hodrzanska H, Low DE, et al. The rapid emergence of a single clone of high-level penicillin-resistant Streptococcus pneumoniae in southwestern Ontario [Abstract J179]. Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, October 4 to 7, 1994.
29. Low DE, Gregson D, Kanchana MB, et al. The rapid emergence of penicillin-resistant Streptococcus pneumoniae (PRSP) in Ontario [Abstract C22]. Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, October 4 to 7, 1994.
30. Naraqi S, Kirkpatric GP, Kabin S. Relapsing pneumococcal meningitis: isolation of an organism with decreased susceptibility to penicillin G. J Pediatr 1974;85:671-3.
31. Appelbaum PC. Emerging resistance to antimicrobial agents in Gram-positive bacteria. Drugs 1996;51(Suppl 1):1-5.
32. Doern GV, Brueggemann A, Holley HP, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agent Chemother 1996;40: 1208-13.
33. Versalovic J, Kapur V, Mason EO, et al. Penicillin-resistant Streptococcus pneumoniae strains recovered in Houston: identification and molecular characterization of multiple clones. J Infect Dis 1993;167:850-6.
34. McDougal LK, Facklam R, Reeves M, et al. Analysis of multiresistant antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States. Antimicrob Agents Chemother 1992;36:2176-84.
35. Spika JS, Facklam RR, Plikaytis BD, Oxtoby MJ, and the Pneumococcal Surveillance Working Group. Antimicrobial resistance of Streptococcal pneumoniae in the United States, 1979-1987. J Infect Dis 1991;163:1273-8.
36. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 1990;34:2075-80.
37. Breiman RF, Butler JC, Tenover FC, Elliot JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994;271:1831-5.
38. Mason EO, Lamberth L, Lichenstein R, Kaplan SL. Distribution of Streptococcus pneumoniae resistant to penicillin in the USA and the in vitro susceptibility to selected oral antibiotics. J Antimicrob Chemother 1995;36:1043-8.
39. Mason EO, Kaplan SL. Penicillin-resistant pneumococci in the United States. Pediatr Infect Dis J 1995;14:1017-8.
40. Simpson EH, Carter ML. Prevalence of penicillin-resistant Streptococcus pneumoniae: Connecticut, 1992-1993. JAMA 1994;271:1572.
41. Arctic Investigations Laboratory Centers for Disease Control. Partial penicillin resistance (PRP) pneumococcal isolates recovered from Alaskan patients. Alaska Med 1987;29:186-7.
42. Hoffman J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995;333:481-6.
43. Evans TG, Kamara A, Minnick K, Blevins D, Sosnowski K. Pneumococcal resistance in southwest Virginia. Antimicrob Agents Chemother 1995;39:985-6.
44. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J 1995;14:751-9.
45. Fairchok MP, Ashton WS, Fischer GW. Carriage of penicillin-resistant pneumococci in a military population in Washington, DC: risk factors and correlation with clinical isolates. Clin Infect Dis 1996;22:966-72.
46. Murray BE. New aspects of antimicrobial resistance and the resulting therapeutic dilemmas. J Infect Dis 1991;163:1185-94.
47. Jacobs MR, Appelbaum PC. Antibiotic resistant pneumococci. Rev Med Microbiol 1995;6:77-93.
48. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests: sixth informational supplement M 100-S6. Villanova, PA: National Committee for Clinical Laboratory Standards, 1995.
49. Jacobs MR. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin Infect Dis 1992;15:119-27.
50. Carroll K, Cohen S, Saxon B, Hamilton L. Failure of Micro Media FOX microdilution system to detect decreased susceptibility of Streptococcus pneumoniae to penicillin. J Clin Microbiol 1991;29:2651-2.
51. Shanholtzer CJ, Peterson LR. False susceptible penicillin G MICs for Streptococcus pneumoniae with a commercial microdilution system. Am J Clin Pathol 1986;85:626-9.
52. Jorgensen JH, Ferraro MJ, McElmeel ML, Spargo J, Swenson JM, Tenover FC. Detection of penicillin and extended spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test. J Clin Microbiol 1994;32:159-63.
53. D'Amato RF, Swenson JM, McKinley GA, et al. Quantitative antimicrobial susceptibility test for Streptococcus pneumoniae using inoculum supplemented with whole defibrinated sheep blood. J Clin Microbiol 1987;25:1753-6.
54. Spangler SK, Jacobs MR, Pankuch GA, Appelbaum PC. Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829. J Antimicrob Chemother 1993;31:273-80.
55. Spangler SK, Jacobs MR, Appelbaum PC. In vitro susceptibility of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUNY/SY 5555), a new oral penem, compared with those of penicillin G, amoxicillin, amoxicillin/ clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir. Antimicrob Agents Chemother 1994;38:2902-4.
56. Pankuch GA, Jacobs MR, Appelbaum PC. Susceptibility of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone. Antimicrob Agents Chemother 1994;38: 2905-7.
57. Linares J, Perez JL, Garau J, Murgui L, Martin R. Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin, and fourteen beta-lactam antibiotics. J Antimicrob Chemother 1984;13:353-9.
58. Linares J, Alonso T, Perez JL, et al. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics. J Antimicrob Chemother 1992;30:279-88.
59. Tweardy DJ, Jacobs MR, Speck WT. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis. J Antimicrob Chemother 1983;12:133-9.
60. Friedland IR. Cefixime therapy for otitis media. Pediatr Infect Dis J 1993;12:544-5.
61. Nelson CT, Mason EO Jr, Kaplan SL. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J 1994;13:585-9.
62. Spangler SK, Jacobs MR, Appelbaum PC. Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cepirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin. Antimicrob Agents Chemother 1994;38:898-900.
63. Sloas M, Barrett F, Chesney J, et al. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 1992; 11:662-6.
64. Bradley JS, Connor JD. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced sensitivity to beta-lactam antibiotics. Pediatr Infect Dis J 1991;10: 871-2.
65. Klugman KP, Dagan R. Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Antimicrob Agents Chemother 1995;39:1140-6.